Skip to Content

Kaletra (lopinavir/ritonavir) Oral Solution

Audience: Infectious disease specialists, pediatricians, pharmacists, other healthcare professionals

[Posted 08/14/2007] Abbott Laboratories disseminated a Dear Healthcare Provider Letter throughout the world to physicians and pharmacists that prescribe/distribute Kaletra Oral Solution. The letter informed healthcare professionals of an accidental overdose that occurred with a pediatric patient taking Kaletra Oral Solution. The infant received a significantly large dose of Kaletra and subsequently died. Healthcare professionals should pay special attention to accurate calculation of the dose of Kaletra, transcription of the medication order, dispensing information and dosing instructions to minimize the risk for medication errors.

[August 13, 2007 - Dear Healthcare Professional Letter - Abbott]